↓ Skip to main content

AB0 blood group and prognosis in patients with pancreatic cancer

Overview of attention for article published in BMC Cancer, July 2012
Altmetric Badge

Mentioned by

facebook
2 Facebook pages

Citations

dimensions_citation
68 Dimensions

Readers on

mendeley
43 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
AB0 blood group and prognosis in patients with pancreatic cancer
Published in
BMC Cancer, July 2012
DOI 10.1186/1471-2407-12-319
Pubmed ID
Authors

Nuh N Rahbari, Ulrich Bork, Ulf Hinz, Albrecht Leo, Johanna Kirchberg, Moritz Koch, Markus W Büchler, Jürgen Weitz

Abstract

Although blood group 0 is associated with a reduced risk of pancreatic cancer, little is known about the role of AB0 blood group antigens in disease progression. We assessed the prognostic relevance of AB0 blood status in a large cohort of patients with resected pancreatic cancer.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 43 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Netherlands 1 2%
Denmark 1 2%
France 1 2%
Unknown 40 93%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 21%
Student > Ph. D. Student 5 12%
Student > Master 5 12%
Student > Doctoral Student 4 9%
Lecturer > Senior Lecturer 4 9%
Other 7 16%
Unknown 9 21%
Readers by discipline Count As %
Medicine and Dentistry 16 37%
Biochemistry, Genetics and Molecular Biology 8 19%
Agricultural and Biological Sciences 2 5%
Engineering 2 5%
Chemistry 2 5%
Other 1 2%
Unknown 12 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 14 February 2013.
All research outputs
#18,329,207
of 22,696,971 outputs
Outputs from BMC Cancer
#5,415
of 8,253 outputs
Outputs of similar age
#125,945
of 164,526 outputs
Outputs of similar age from BMC Cancer
#64
of 81 outputs
Altmetric has tracked 22,696,971 research outputs across all sources so far. This one is in the 11th percentile – i.e., 11% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,253 research outputs from this source. They receive a mean Attention Score of 4.3. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 164,526 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 10th percentile – i.e., 10% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 81 others from the same source and published within six weeks on either side of this one. This one is in the 2nd percentile – i.e., 2% of its contemporaries scored the same or lower than it.